RecruitingNCT05046080
Clinicopathologic and Ancillary Testing of Primary Clear Cell Carcinoma of the Cervix
Clinicopathologic and Ancillary Testing of Primary Clear Cell Carcinoma of the Cervix - a Rare Tumor
Sponsor
M.D. Anderson Cancer Center
Enrollment
70 participants
Start Date
Aug 6, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
This study aims to provide a comprehensive report on clinicopathologic features, immunohistochemical/biomarker testing and molecular profile of cervical clear cell carcinoma. This study may help researchers learn more about the molecular profile of cervical clear cell carcinoma.
Eligibility
Sex: FEMALE
Inclusion Criteria1
- Patients diagnosed with clear cell carcinoma of the cervix at MDACC
Interventions
OTHERElectronic Health Record Review
Medical records reviewed
OTHERLaboratory Biomarker Analysis
Correlative studies
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05046080